相关实验视频
Updated: May 24, 2025

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.0K
慢性髓性白血病的不同体外模型显示了不同的特征:生物复制品不是生物学等价的生物复制品
Alessia Cavalleri1,2, Besjana Xhahysa1,2, Silvia Mutti1,2
1Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Diseases and Bone Marrow Transplant, ASST Spedali Civili, Brescia, Italy.
Cell biology international
|March 1, 2025
概括
慢性髓性白血病 (CML) 细胞系对氨酸激酶抑制剂 (TKI) 和STAMP抑制剂的反应不同. 这凸显了细胞异质性对于完善CML临床前模型和治疗策略的重要性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性髓性白血病 (CML) 是由BCR::ABL1融合基因驱动的,导致无法控制的细胞生长.
- 代谢失调是CML进展的一个关键因素.
- 现有的氨酸激酶抑制剂 (TKI) 是有效的,但不能完全满足临床需求,需要更好的临床前模型.
研究的目的:
- 为了比较三个不同的CML细胞系 (K562,LAMA84,KCL22) 对五种TKI和一种STAMP抑制剂的反应.
- 评估这些抑制剂对细胞形态,活力,新陈代谢和基因表达的影响.
- 要强调细胞异质性在CML研究中的重要性.
主要方法:
- 形态学评估 形态学评估
- 细胞活力和代谢活动测试.
- 谷氨酸摄入量的评估
- 基因表达分析分析基因表达.
主要成果:
- 在用TKIs和STAMP抑制剂治疗时,在三个CML细胞系中观察到明显的细胞反应.
- 抑制剂治疗对细胞形态,活力,代谢活性和基因表达特征表现出不同的影响.
- 细胞反应的显著差异强调了CML细胞系之间固有的异质性.
结论:
- 对TKI和STAMP抑制剂的CML细胞系反应是异质的.
- 这种异质性需要在选择临床前模型进行CML研究时仔细考虑.
- 了解这些不同的反应可以提高临床前研究的翻译相关性,并有助于开发更有效的CML治疗方法.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Cell Lines
7.1K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
7.1K

